Who Paid My Doc
Melissa Bibb
Nurse Practitioner, Family Seminole, FL Nurse Practitioner
NPI 1063865608 CMS profile 10663238
9555 Seminole Blvd, Suite 104, Seminole, FL 33772
General payments
$1,704
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Melissa Bibb of Seminole, FL is reported in the CMS Open Payments database as having received $1,704 across 58 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 80th percentile of Nurse Practitioner, Family profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $1,101 | 39 | |
| 2022 | General | $530 | 15 | |
| 2021 | General | $74 | 4 |
Beside peers
- Melissa Bibb
- Nurse Practitioner, Family median
- Middle half of Nurse Practitioner, Family
- National median
In program year 2025, general payments to Melissa Bibb were reported at $0. Among 107,232 Nurse Practitioner, Family profiles paid that year, the median was $168 and the middle half received between $53 and $521.
Show as a table
| Year | Melissa Bibb | Nurse Practitioner, Family median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $39 | $18–$91 | $163 |
| 2020 | $0 | $32 | $17–$76 | $114 |
| 2021 | $74 | $124 | $35–$379 | $132 |
| 2022 | $530 | $141 | $44–$430 | $149 |
| 2023 | $1,101 | $154 | $49–$476 | $160 |
| 2024 | $0 | $165 | $51–$504 | $164 |
| 2025 | $0 | $168 | $53–$521 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 248 drugsPart D claims
30,654
Drug cost
$1,812,659
Branded share of claims
16.6%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | Brand | 375 | $171,123 | |
| Eliquis Apixaban | Brand | 281 | $137,515 | |
| Myrbetriq Mirabegron | Brand | 253 | $110,287 | |
| Linzess Linaclotide | Brand | 197 | $108,982 | |
| Xarelto Rivaroxaban | Brand | 206 | $104,920 | |
| Gemtesa Vibegron | Brand | 155 | $77,437 | |
| Xifaxan Rifaximin | Brand | 20 | $63,756 | |
| Ozempic Semaglutide | Brand | 48 | $48,091 | |
| Vraylar Cariprazine Hcl | Brand | 32 | $47,447 | |
| Mounjaro Tirzepatide | Brand | 42 | $46,711 |
The 10 drugs with the highest cost, of 248 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 27 billing codesPaid by Medicare
$188,900
Medicare patients
435
Services billed
3,799
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 74% | |
| Depression | 51% | |
| Diabetes | 36% | |
| Arthritis | 32% | |
| Alzheimer's or dementia | 29% | |
| COPD | 27% | |
| Chronic kidney disease | 23% | |
| Ischemic heart disease | 19% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Influenza vaccine, trivalent, 0.5 ml dosage 90658 | Office | 230 | 230 | $4,927 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
58 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner, Family in Florida
Lewis Harrington
Nurse Practitioner, Family · Tampa, FL
Danielle Phares
Nurse Practitioner, Family · Ft Lauderdale, FL
Donna Ortiz
Nurse Practitioner, Family · Orlando, FL
Patrick Szaraz
Nurse Practitioner, Family · Miami, FL
Deena Rodney
Nurse Practitioner, Family · Maitland, FL
Yamila Melendez
Nurse Practitioner, Family · Miami, FL
Related records
Nurse Practitioner, Family in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner, Family
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.